Cargando…

Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis

Rheumatoid Arthritis (RA) remains a major global public health challenge. Disease-modifying anti-rheumatic drugs (DMARDs) are standard therapeutic drugs for RA. Conventional DMARDs (c-DMARDs) are a subgroup of approved synthetic DMARDs. The c-DMARDs experienced lesser response with longer disease du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Rong, Ren, Hong Cheng, Zhou, Sitong, Gu, Sherman, Gu, Yue-Yu, Sze, Daniel Man-yuen, Chen, Meng-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446108/ https://www.ncbi.nlm.nih.gov/pubmed/36081815 http://dx.doi.org/10.1016/j.jtcme.2022.01.005

Ejemplares similares

Epimedii Herba: An ancient Chinese herbal medicine in the prevention and treatment of rheumatoid arthritis
por: Zhang, Liu-Bo, et al.
Publicado: (2022)

A Comparison of the Risk of Fracture in Rheumatoid Arthritis Patients with and without Receiving Chinese Herbal Medicine
por: Liao, Hou-Hsun, et al.
Publicado: (2021)

Combination effects of herbal and western medicines on osteoporosis in rheumatoid arthritis: systematic review and meta-analysis
por: Kwon, Do Young, et al.
Publicado: (2023)

Gout, Rheumatism, and Rheumatoid Arthritis
Publicado: (1900)

Chronic Rheumatism and Rheumatoid Arthritis
por: Lindsay, J.
Publicado: (1908)

The risk of coronary artery disease in patients with rheumatoid arthritis using Chinese herbal products and conventional medicine in parallel: a population-based cohort study
por: Yu, Han-Hua, et al.
Publicado: (2020)

Lessons Learnt from Evidence-Based Approach of Using Chinese Herbal Medicines in Liver Cancer
por: Zheng, Zhan, et al.
Publicado: (2013)

New Exploration of Chinese Herbal Medicines in Hepatology
por: Feng, Yibin, et al.
Publicado: (2016)

Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis
por: Fan, Arthur Yin, et al.
Publicado: (2020)

Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis
por: Pan, Xin, et al.
Publicado: (2017)

Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products
por: Xia, Xuan, et al.
Publicado: (2020)

Effect of Chinese Herbal Medicines on Hearing Loss Risk in Rheumatoid Arthritis Patients: Retrospective Claims Analysis
por: Li, Hsin-Hua, et al.
Publicado: (2021)

A Treatise on Rheumatism and Rheumatoid Arthritis
Publicado: (1892)

Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
por: Rivellese, Felice, et al.
Publicado: (2020)

Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea
por: Ha, So-Young, et al.
Publicado: (2021)

Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis
por: Alpay-Kanitez, Nilüfer, et al.
Publicado: (2020)

Indian Herbal Medicines: Possible Potent Therapeutic Agents for Rheumatoid Arthritis
por: Rathore, Brijesh, et al.
Publicado: (2007)

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
por: Xia, Yunfei, et al.
Publicado: (2016)

The Prescription of Chinese Herbal Medicine and Risk of Endometriosis in Women with Rheumatoid Arthritis: A Population-Based Cohort Study
por: Chen, Chia-Jung, et al.
Publicado: (2022)

Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis
por: Wood, Patrick R, et al.
Publicado: (2018)

Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent
por: Senbel, Eric, et al.
Publicado: (2021)

Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
por: Zhao, Sizheng Steven, et al.
Publicado: (2022)

Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
por: Giachi, Andrea, et al.
Publicado: (2022)

Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
por: Das, Priyam, et al.
Publicado: (2023)

Cataphoresis in the Treatment of Gout, Rheumatism, and Rheumatoid Arthritis
por: Begg, Charles
Publicado: (1902)

The Differential Diagnosis of Gout, Rheumatism, and Rheumatoid Arthritis
por: Luff, Arthur P.
Publicado: (1900)

Antiarthritic Activity of Qi-Wu Rheumatism Granule (a Chinese Herbal Compound) on Complete Freund's Adjuvant-Induced Arthritis in Rats
por: Xu, Qi, et al.
Publicado: (2017)

Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
por: Lee, Wen-Yuan, et al.
Publicado: (2014)

Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
por: Choy, Ernest H
Publicado: (2019)

Exploring the treatment burden of disease-modifying anti-rheumatic drug monitoring in people with rheumatoid arthritis
por: Ryan, Sarah, et al.
Publicado: (2023)

Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
por: Su, Yu-Jih, et al.
Publicado: (2023)

Research Progress of Therapeutic Enzymes and Their Derivatives: Based on Herbal Medicinal Products in Rheumatoid Arthritis
por: Cai, Ming, et al.
Publicado: (2021)

Applications and potential mechanisms of herbal medicines for rheumatoid arthritis treatment: a systematic review
por: Li, Tai-ping, et al.
Publicado: (2019)

Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis
por: Li, Ruo-Lan, et al.
Publicado: (2022)

Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient’s perspective
por: Pascual-Ramos, Virginia, et al.
Publicado: (2013)

Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs
por: Heidari, Behzad, et al.
Publicado: (2012)

Gene expression of Interleukin-18 in rheumatoid arthritis patients on disease modifying anti-rheumatic drug therapy
por: Khalid, Sabeen, et al.
Publicado: (2019)

Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2020)

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs
por: Arias de la Rosa, Iván, et al.
Publicado: (2021)

Effect of glucocorticoids combined with disease modifying anti-rheumatic drugs on the improvement of symptoms in patients with rheumatoid arthritis
por: Si, Lulu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a8cuk9ldfhildvn0jqmlbaa7qk